ArticleMedical oncology (Northwood, London, England)2018

Comparison of the clinical outcomes of nilotinib and dasatinib therapies in newly diagnosed patients in the chronic phase of chronic myeloid leukemia: a retrospective analysis.

Noriyoshi Iriyama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.